 |
PDBsum entry 1c3d
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Science
280:1277-1281
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2.
|
|
B.Nagar,
R.G.Jones,
R.J.Diefenbach,
D.E.Isenman,
J.M.Rini.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Activation and covalent attachment of complement component C3 to pathogens is
the key step in complement-mediated host defense. Additionally, the
antigen-bound C3d fragment interacts with complement receptor 2 (CR2; also known
as CD21) on B cells and thereby contributes to the initiation of an acquired
humoral response. The x-ray crystal structure of human C3d solved at 2.0
angstroms resolution reveals an alpha-alpha barrel with the residues responsible
for thioester formation and covalent attachment at one end and an acidic pocket
at the other. The structure supports a model whereby the transition of native C3
to its functionally active state involves the disruption of a complementary
domain interface and provides insight into the basis for the interaction between
C3d and CR2.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Sequence conservation of C3d. (A) Multiple sequence
alignment of selected species of C3d and human C4d (B isotype)
(21). Residues shaded in yellow are at least 90% buried in the^
C3d structure, and those shaded in red are residues composing
the contiguous surface patch labeled in (B). Numbers correspond^
to the degree of conservation in C3d sequences only: 0 (not
conserved) to A (highly conserved), as determined by the program
AMAS (32). In human C4d, approximately 75% of the core residues,
as well as the putative domain interface residues, are highly
conserved^ [a conservation index (cons. index) of 7 or higher
when included^ in the AMAS calculation], which suggests that it
will adopt a^ similar fold and possess the analogous domain
interface. The helical segments in human C3d are indicated by
blue cylinders. [The figure^ was prepared with ALSCRIPT (35).]
(B) Mapping of residue^ conservation as determined in (A) onto
the surface of C3d; white^ (not conserved) to progressively
darker red (highly conserved). [The figure was prepared with
GRASP (36).] The conserved patch includes most of the surface
apolar residues shown in Fig. 1C.
|
 |
Figure 3.
Fig. 3. Stereo view of an electrostatic surface rendition of
C3d, showing the acidic pocket on the concave end of the
molecule. Acidic^ and basic residues are colored red and blue,
respectively. Labeled^ are the surface-exposed residues that
form the pocket. The contour level is at ±10 kT.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the AAAs:
Science
(1998,
280,
1277-1281)
copyright 1998.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.A.Kieslich,
D.Morikis,
J.Yang,
and
D.Gunopulos
(2011).
Automated computational framework for the analysis of electrostatic similarities of proteins.
|
| |
Biotechnol Prog,
27,
316-325.
|
 |
|
|
|
|
 |
H.P.Morgan,
C.Q.Schmidt,
M.Guariento,
B.S.Blaum,
D.Gillespie,
A.P.Herbert,
D.Kavanagh,
H.D.Mertens,
D.I.Svergun,
C.M.Johansson,
D.Uhrín,
P.N.Barlow,
and
J.P.Hannan
(2011).
Structural basis for engagement by complement factor H of C3b on a self surface.
|
| |
Nat Struct Mol Biol,
18,
463-470.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.van den Elsen,
and
D.E.Isenman
(2011).
A crystal structure of the complex between human complement receptor 2 and its ligand C3d.
|
| |
Science,
332,
608-611.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Kajander,
M.J.Lehtinen,
S.Hyvärinen,
A.Bhattacharjee,
E.Leung,
D.E.Isenman,
S.Meri,
A.Goldman,
and
T.S.Jokiranta
(2011).
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.
|
| |
Proc Natl Acad Sci U S A,
108,
2897-2902.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.Liu,
J.Wang,
and
Z.X.Niu
(2010).
Contribution of Chinese Pekin duck complement component C3d-P29 repeats to enhancement of Th2-biased immune responses against NDV F gene induced by DNA immunization.
|
| |
Immunopharmacol Immunotoxicol,
32,
297-306.
|
 |
|
|
|
|
 |
D.Serruto,
R.Rappuoli,
M.Scarselli,
P.Gros,
and
J.A.van Strijp
(2010).
Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.
|
| |
Nat Rev Microbiol,
8,
393-399.
|
 |
|
|
|
|
 |
J.R.Dunkelberger,
and
W.C.Song
(2010).
Complement and its role in innate and adaptive immune responses.
|
| |
Cell Res,
20,
34-50.
|
 |
|
|
|
|
 |
M.G.Castillo,
M.S.Goodson,
and
M.McFall-Ngai
(2009).
Identification and molecular characterization of a complement C3 molecule in a lophotrochozoan, the Hawaiian bobtail squid Euprymna scolopes.
|
| |
Dev Comp Immunol,
33,
69-76.
|
 |
|
|
|
|
 |
M.J.Lehtinen,
A.L.Rops,
D.E.Isenman,
J.van der Vlag,
and
T.S.Jokiranta
(2009).
Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
|
| |
J Biol Chem,
284,
15650-15658.
|
 |
|
|
|
|
 |
D.Liu,
J.Y.Zhu,
and
Z.X.Niu
(2008).
Molecular structure and expression of anthropic, ovine, and murine forms of complement receptor type 2.
|
| |
Clin Vaccine Immunol,
15,
901-910.
|
 |
|
|
|
|
 |
D.Ricklin,
S.K.Ricklin-Lichtsteiner,
M.M.Markiewski,
B.V.Geisbrecht,
and
J.D.Lambris
(2008).
Cutting edge: members of the Staphylococcus aureus extracellular fibrinogen-binding protein family inhibit the interaction of C3d with complement receptor 2.
|
| |
J Immunol,
181,
7463-7467.
|
 |
|
|
|
|
 |
H.Chen,
M.C.Schuster,
G.Sfyroera,
B.V.Geisbrecht,
and
J.D.Lambris
(2008).
Solution insights into the structure of the Efb/C3 complement inhibitory complex as revealed by lysine acetylation and mass spectrometry.
|
| |
J Am Soc Mass Spectrom,
19,
55-65.
|
 |
|
|
|
|
 |
J.D.Burman,
E.Leung,
K.L.Atkins,
M.N.O'Seaghdha,
L.Lango,
P.Bernadó,
S.Bagby,
D.I.Svergun,
T.J.Foster,
D.E.Isenman,
and
J.M.van den Elsen
(2008).
Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus.
|
| |
J Biol Chem,
283,
17579-17593.
|
 |
|
|
|
|
 |
N.Doan,
and
P.G.Gettins
(2008).
alpha-Macroglobulins are present in some gram-negative bacteria: characterization of the alpha2-macroglobulin from Escherichia coli.
|
| |
J Biol Chem,
283,
28747-28756.
|
 |
|
|
|
|
 |
N.Haspel,
D.Ricklin,
B.V.Geisbrecht,
L.E.Kavraki,
and
J.D.Lambris
(2008).
Electrostatic contributions drive the interaction between Staphylococcus aureus protein Efb-C and its complement target C3d.
|
| |
Protein Sci,
17,
1894-1906.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Gros,
F.J.Milder,
and
B.J.Janssen
(2008).
Complement driven by conformational changes.
|
| |
Nat Rev Immunol,
8,
48-58.
|
 |
|
|
|
|
 |
D.Ricklin,
and
J.D.Lambris
(2007).
Complement-targeted therapeutics.
|
| |
Nat Biotechnol,
25,
1265-1275.
|
 |
|
|
|
|
 |
M.Hammel,
G.Sfyroera,
D.Ricklin,
P.Magotti,
J.D.Lambris,
and
B.V.Geisbrecht
(2007).
A structural basis for complement inhibition by Staphylococcus aureus.
|
| |
Nat Immunol,
8,
430-437.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Roversi,
O.Lissina,
S.Johnson,
N.Ahmat,
G.C.Paesen,
K.Ploss,
W.Boland,
M.A.Nunn,
and
S.M.Lea
(2007).
The structure of OMCI, a novel lipocalin inhibitor of the complement system.
|
| |
J Mol Biol,
369,
784-793.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.H.Baxter,
C.I.Chang,
Y.Chelliah,
S.Blandin,
E.A.Levashina,
and
J.Deisenhofer
(2007).
Structural basis for conserved complement factor-like function in the antimalarial protein TEP1.
|
| |
Proc Natl Acad Sci U S A,
104,
11615-11620.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Abdul Ajees,
K.Gunasekaran,
J.E.Volanakis,
S.V.Narayana,
G.J.Kotwal,
and
H.M.Murthy
(2006).
The structure of complement C3b provides insights into complement activation and regulation.
|
| |
Nature,
444,
221-225.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.J.Janssen,
A.Christodoulidou,
A.McCarthy,
J.D.Lambris,
and
P.Gros
(2006).
Structure of C3b reveals conformational changes that underlie complement activity.
|
| |
Nature,
444,
213-216.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Szakonyi,
M.G.Klein,
J.P.Hannan,
K.A.Young,
R.Z.Ma,
R.Asokan,
V.M.Holers,
and
X.S.Chen
(2006).
Structure of the Epstein-Barr virus major envelope glycoprotein.
|
| |
Nat Struct Mol Biol,
13,
996.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Zhang,
and
D.Morikis
(2006).
Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.
|
| |
Biophys J,
90,
3106-3119.
|
 |
|
|
|
|
 |
N.Nishida,
T.Walz,
and
T.A.Springer
(2006).
Structural transitions of complement component C3 and its activation products.
|
| |
Proc Natl Acad Sci U S A,
103,
19737-19742.
|
 |
|
|
|
|
 |
T.S.Jokiranta,
V.P.Jaakola,
M.J.Lehtinen,
M.Pärepalo,
S.Meri,
and
A.Goldman
(2006).
Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.
|
| |
EMBO J,
25,
1784-1794.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.S.Jokiranta
(2006).
C3b and factor H: key components of the complement system.
|
| |
Expert Rev Clin Immunol,
2,
775-786.
|
 |
|
|
|
|
 |
B.J.Janssen,
E.G.Huizinga,
H.C.Raaijmakers,
A.Roos,
M.R.Daha,
K.Nilsson-Ekdahl,
B.Nilsson,
and
P.Gros
(2005).
Structures of complement component C3 provide insights into the function and evolution of immunity.
|
| |
Nature,
437,
505-511.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.J.Dishaw,
S.L.Smith,
and
C.H.Bigger
(2005).
Characterization of a C3-like cDNA in a coral: phylogenetic implications.
|
| |
Immunogenetics,
57,
535-548.
|
 |
|
|
|
|
 |
R.Liddington,
and
L.Bankston
(2005).
Structural biology: origins of chemical biodefence.
|
| |
Nature,
437,
484-485.
|
 |
|
|
|
|
 |
K.A.Kantardjieff,
P.Höchtl,
B.W.Segelke,
F.M.Tao,
and
B.Rupp
(2002).
Concanavalin A in a dimeric crystal form: revisiting structural accuracy and molecular flexibility.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
735-743.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.A.Levashina,
L.F.Moita,
S.Blandin,
G.Vriend,
M.Lagueux,
and
F.C.Kafatos
(2001).
Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae.
|
| |
Cell,
104,
709-718.
|
 |
|
|
|
|
 |
K.H.Murthy,
S.A.Smith,
V.K.Ganesh,
K.W.Judge,
N.Mullin,
P.N.Barlow,
C.M.Ogata,
and
G.J.Kotwal
(2001).
Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans.
|
| |
Cell,
104,
301-311.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Sharma,
T.Jabeen,
R.K.Singh,
R.Bredhorst,
C.W.Vogel,
C.Betzel,
and
T.P.Singh
(2001).
Structural studies on the cobra venom factor: isolation, purification, crystallization and preliminary crystallographic analysis.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
596-598.
|
 |
|
|
|
|
 |
D.Hourcade,
M.K.Liszewski,
M.Krych-Goldberg,
and
J.P.Atkinson
(2000).
Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
|
| |
Immunopharmacology,
49,
103-116.
|
 |
|
|
|
|
 |
F.Vallée,
F.Lipari,
P.Yip,
B.Sleno,
A.Herscovics,
and
P.L.Howell
(2000).
Crystal structure of a class I alpha1,2-mannosidase involved in N-glycan processing and endoplasmic reticulum quality control.
|
| |
EMBO J,
19,
581-588.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Lindahl,
U.Sjöbring,
and
E.Johnsson
(2000).
Human complement regulators: a major target for pathogenic microorganisms.
|
| |
Curr Opin Immunol,
12,
44-51.
|
 |
|
|
|
|
 |
H.Zhang,
M.C.Seabra,
and
J.Deisenhofer
(2000).
Crystal structure of Rab geranylgeranyltransferase at 2.0 A resolution.
|
| |
Structure,
8,
241-251.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Uwai,
Y.Terui,
Y.Mishima,
H.Tomizuka,
M.Ikeda,
T.Itoh,
M.Mori,
M.Ueda,
R.Inoue,
M.Yamada,
H.Hayasawa,
T.Horiuchi,
Y.Niho,
M.Matsumoto,
Y.Ishizaka,
K.Ikeda,
K.Ozawa,
and
K.Hatake
(2000).
A new apoptotic pathway for the complement factor B-derived fragment Bb.
|
| |
J Cell Physiol,
185,
280-292.
|
 |
|
|
|
|
 |
P.L.Howell,
R.H.Blessing,
G.D.Smith,
and
C.M.Weeks
(2000).
Optimizing DREAR and SnB parameters for determining Se-atom substructures.
|
| |
Acta Crystallogr D Biol Crystallogr,
56,
604-617.
|
 |
|
|
|
|
 |
W.M.Prodinger
(1999).
Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trapping.
|
| |
Immunol Res,
20,
187-194.
|
 |
|
|
|
|
 |
W.S.Hlavacek,
C.Wofsy,
and
A.S.Perelson
(1999).
Dissociation of HIV-1 from follicular dendritic cells during HAART: mathematical analysis.
|
| |
Proc Natl Acad Sci U S A,
96,
14681-14686.
|
 |
|
|
|
|
 |
A.W.Dodds,
and
S.K.Law
(1998).
The phylogeny and evolution of the thioester bond-containing proteins C3, C4 and alpha 2-macroglobulin.
|
| |
Immunol Rev,
166,
15-26.
|
 |
|
|
|
|
 |
J.O.Sunyer,
and
J.D.Lambris
(1998).
Evolution and diversity of the complement system of poikilothermic vertebrates.
|
| |
Immunol Rev,
166,
39-57.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |